New Strategies for Heart Failure Patients Improves Outcomes
One-third of heart failure patients do not respond to cardiac resynchronization therapy (CRT) | A coordinated care approach at Mass General for heart failure patients improves outcomes.
The Promise of Ventricular-Assist Devices (VADs)
VAD technology is continually improving. Mass General data indicates new VADs improve 5-year survival rates. Trials for the latest generation are under way.
Frailty Status Affects Outcomes of Medicare Beneficiaries Hospitalized With HF
Tamra Keeney, DPT, PhD, and team found that from 2008–2015, post-acute care use increased among frail Medicare beneficiaries discharged after hospitalization for heart failure. Although the number of days spent alive at home improved, mortality and readmission rates were highest among beneficiaries classified as frail.
Ex Vivo Perfusion and Transplantation of Hearts Donated After Circulatory Death Is Safe and Effective
Massachusetts General Hospital researchers found transplantation of hearts donated after circulatory death and preserved with a proprietary ex vivo warm perfusion system was safe and effective compared with control subjects who received hearts donated after brain death. The one-year survival rate was 97%.
Short Term Mechanical Support Heart and Lung Symposium 2023
Experts from the Corrigan Minehan Heart Center of Massachusetts General Hospital are leading a course designed to educate participants in the multidisciplinary care of patients with acute heart and lung failure.
Virtual Randomized Trial Feasible, Demonstrates Canagliflozin Relieves Symptom Burden in HF
James L. Januzzi, MD, and colleagues conducted a large randomized, placebo-controlled trial without any in-person visits, demonstrating canagliflozin was associated with a rapid and clinically meaningful improvement in the symptoms of heart failure regardless of ejection fraction and presence of diabetes.
Heart Failure Contributors
James Louis Januzzi, MD
Director, Dennis and Marilyn Barry Fellowship in Cardiology Research, Cardiologist, Corrigan Minehan Heart Center, Massachusetts General Hospital, Hutter Family Professor of Medicine in the Field of Cardiology, Harvard Medical School
Multi-Biomarker Panel Predicts CV Events in Patients With Chronic Kidney Disease
Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery, Co-Director, Corrigan Minehan Heart Center, Director, Cardiac Surgery Clinical Service, Mass General Brigham
Treating Pericardial Disease